ACRS
Aclaris Therapeutics Inc
Price:  
1.45 
USD
Volume:  
733,074.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Aclaris Relative Valuation

-1640.5%
Upside

As of 2025-07-04, the Relative Valuation of Aclaris Therapeutics Inc (ACRS) is (22.34) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.45 USD, the upside of Aclaris Therapeutics Inc based on Relative Valuation is -1640.5%.

The range of the Relative Valuation is (21.48) - (22.15) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 17.6x - 18.4x 18.1x
Forward P/E multiples 17.9x - 20.5x 19.0x
Fair Price (21.48) - (22.15) (22.34)
Upside -1581.2% - -1627.6% -1640.5%
1.45 USD
Stock Price
(22.34) USD
Fair Price

Aclaris Relative Valuation - Historical P/E Data

Date P/E
2025-07-02 -1.21
2025-07-01 -1.17
2025-06-30 -1.18
2025-06-27 -1.22
2025-06-26 -1.30
2025-06-25 -1.36
2025-06-24 -1.26
2025-06-23 -1.16
2025-06-20 -1.21
2025-06-18 -1.18
2025-06-17 -1.16
2025-06-16 -1.20
2025-06-13 -1.22
2025-06-12 -1.27
2025-06-11 -1.31
2025-06-10 -1.26
2025-06-09 -1.24
2025-06-06 -1.27
2025-06-05 -1.30
2025-06-04 -1.34
2025-06-03 -1.22
2025-06-02 -1.20
2025-05-30 -1.21
2025-05-29 -1.21
2025-05-28 -1.17
2025-05-27 -1.06
2025-05-23 -1.05
2025-05-22 -1.05
2025-05-21 -1.07
2025-05-20 -1.12
2025-05-19 -1.08
2025-05-16 -1.09
2025-05-15 -1.01
2025-05-14 -0.98
2025-05-13 -1.01
2025-05-12 -1.04
2025-05-09 -1.05
2025-05-08 -1.09
2025-05-07 -1.04
2025-05-06 -1.06
2025-05-05 -1.06
2025-05-02 -1.20
2025-05-01 -1.15
2025-04-30 -1.15
2025-04-29 -1.11
2025-04-28 -1.13
2025-04-25 -1.11
2025-04-24 -1.06
2025-04-23 -0.99
2025-04-22 -0.91